Treatment of chronic HBV infection in developing countries

Treatment of chronic HBV infection in developing countries

Due to virological, host and socio-economic factors, the clinical presentation and treatment of chronic hepatitis B (CHB) differs between developing and developed countries and may differ between one low-income country and another. National healthcare prevention and treatment policies, environmental...

Full description

Bibliographic Details
Main Authors: Rosa Zampino, Caterina Sagnelli, Adriana Boemio, Evangelista Sagnelli, Nicola Coppola
Format: Article
Language:English
Published: Elsevier 2016-11-01
Series:Annals of Hepatology
Subjects:
Chronic hepatitis B
Asia
Africa
Eastern Europe
Latin America
Online Access:http://www.sciencedirect.com/science/article/pii/S166526811931107X
id doaj-9509740e09b04d868cfcfa58abe9722c
record_format Article
spelling doaj-9509740e09b04d868cfcfa58abe9722c2021-06-09T05:53:30ZengElsevierAnnals of Hepatology1665-26812016-11-01156816823Treatment of chronic HBV infection in developing countriesRosa Zampino0Caterina Sagnelli1Adriana Boemio2Evangelista Sagnelli3Nicola Coppola4Internal Medicine and Hepatology, Second University of Naples, Naples, Italy; Correspondence and reprint request:Department of Clinical and Experimental Medicine and Surgery “F. Magrassi e A. Lanzara”, Second University of Naples, Naples, ItalyInternal Medicine and Hepatology, Second University of Naples, Naples, ItalyDepartment of Mental Health and Public Medicine, Honorary Professor of Infectious Diseases, Second University of Naples, Naples, ItalyDepartment of Mental Health and Public Medicine, Section of Infectious Diseases. Second University of Naples, Naples, ItalyDue to virological, host and socio-economic factors, the clinical presentation and treatment of chronic hepatitis B (CHB) differs between developing and developed countries and may differ between one low-income country and another. National healthcare prevention and treatment policies, environmental factors, social habits and personal life-styles all influence HBV transmission and the clinical management and therapy of CHB. These factors can have a strong impact on the natural history of the disease and on access to treatment and may eventually determine substantial changes in disease progression and the development of serious complications and hepatocellular carcinoma. In this review article, we analyze the clinical characteristics and access to antiviral treatment of CHB patients in low-income countries in Africa, Asia, Eastern Europe and Latin America.http://www.sciencedirect.com/science/article/pii/S166526811931107XChronic hepatitis BAsiaAfricaEastern EuropeLatin America
collection DOAJ
language English
format Article
sources DOAJ
author Rosa Zampino
Caterina Sagnelli
Adriana Boemio
Evangelista Sagnelli
Nicola Coppola
spellingShingle Rosa Zampino
Caterina Sagnelli
Adriana Boemio
Evangelista Sagnelli
Nicola Coppola
Treatment of chronic HBV infection in developing countries
Annals of Hepatology
Chronic hepatitis B
Asia
Africa
Eastern Europe
Latin America
author_facet Rosa Zampino
Caterina Sagnelli
Adriana Boemio
Evangelista Sagnelli
Nicola Coppola
author_sort Rosa Zampino
title Treatment of chronic HBV infection in developing countries
title_short Treatment of chronic HBV infection in developing countries
title_full Treatment of chronic HBV infection in developing countries
title_fullStr Treatment of chronic HBV infection in developing countries
title_full_unstemmed Treatment of chronic HBV infection in developing countries
title_sort treatment of chronic hbv infection in developing countries
publisher Elsevier
series Annals of Hepatology
issn 1665-2681
publishDate 2016-11-01
description Due to virological, host and socio-economic factors, the clinical presentation and treatment of chronic hepatitis B (CHB) differs between developing and developed countries and may differ between one low-income country and another. National healthcare prevention and treatment policies, environmental factors, social habits and personal life-styles all influence HBV transmission and the clinical management and therapy of CHB. These factors can have a strong impact on the natural history of the disease and on access to treatment and may eventually determine substantial changes in disease progression and the development of serious complications and hepatocellular carcinoma. In this review article, we analyze the clinical characteristics and access to antiviral treatment of CHB patients in low-income countries in Africa, Asia, Eastern Europe and Latin America.
topic Chronic hepatitis B
Asia
Africa
Eastern Europe
Latin America
url http://www.sciencedirect.com/science/article/pii/S166526811931107X
work_keys_str_mv AT rosazampino treatmentofchronichbvinfectionindevelopingcountries
AT caterinasagnelli treatmentofchronichbvinfectionindevelopingcountries
AT adrianaboemio treatmentofchronichbvinfectionindevelopingcountries
AT evangelistasagnelli treatmentofchronichbvinfectionindevelopingcountries
AT nicolacoppola treatmentofchronichbvinfectionindevelopingcountries
_version_ 1721388848835985408

Similar Items